Applied DNA Sciences, Inc.
APDN
$0.1314
$0.00181.39%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 19.94% | -275.38% | 142.05% | -304.53% | 69.24% |
| Total Depreciation and Amortization | -23.90% | -42.62% | -27.97% | -37.69% | -9.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -240.69% | 103.19% | -594.39% | 144.92% | -1,157.31% |
| Change in Net Operating Assets | -165.31% | 44.45% | -1,243.28% | 104.86% | -181.83% |
| Cash from Operations | -2.37% | 7.03% | -8.87% | 14.58% | -40.22% |
| Capital Expenditure | 68.52% | -1,603.21% | -47.30% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 68.52% | -1,603.21% | -47.30% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 268.30% | 6,335.96% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 200.00% | -- |
| Cash from Financing | 1,714.08% | -103.61% | 258.46% | 8,690.88% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 171.39% | -155.00% | 3,582.57% | 94.48% | -5.23% |
